UK Launches World's Largest Medical Imaging Research Project with £43 Million Investment

On April 14, the world’s largest medical imaging study, funded by the Medical Research Council, Wellcome Trust (the world’s largest research charity), and the British Heart Foundation, was officially launched. It will create the most comprehensive collection of internal organ scans, transforming how scientists study a range of diseases, including dementia, arthritis, cancer, heart attack, and stroke.



This study involves an investment of £43 million, which will be used to scan and image samples of the brain, heart, bones, carotid arteries, and abdominal fat from 100,000 current participants in the UK Biobank. The project was initiated in 2006 by the Medical Research Council and the Wellcome Trust with the aim of establishing a research resource comprising more than 500,000 individuals in the United Kingdom, thereby improving the health status of the population.

The results of this multi-organ imaging scan will be analyzed in conjunction with the extensive data already collected from UK Biobank participants. Another application of these data is to provide medical scientists with up-to-date insights into the optimal strategies for preventing and treating various diseases, such as arthritis, coronary heart disease, Alzheimer’s disease, and osteoporosis. The exploratory research and analysis of the scan images will benefit future patient analysis and studies.

Over the past decade, UK Biobank has collected extensive data from 500,000 participants—including information on their lifestyle, weight, height, diet, physical activity, and cognitive function, as well as genetic data derived from blood samples. Relevant comprehensive health data have also been recorded.

Cathie Sudlow, Professor of Neurology and Clinical Epidemiology at the University of Edinburgh and Chief Scientist of UK Biobank, stated: “The sheer scale of participation in this imaging study is impressive. However, what is truly transformative is the integration of rich imaging data with other existing information or data collected from participants, particularly their future health and disease outcomes.”

UK Life Sciences Minister George Freeman MP said: “Remarkable advances in imaging and informatics are opening new pathways for the diagnosis, treatment, and prevention of underlying conditions such as dementia, heart disease, and cancer. We have invested £20 million in assembling the world’s largest imaging dataset—helping the UK become a global leader in life sciences in the 21st century.”

Processing Brain Information

This large-scale study will help researchers understand what happens in the brain before the onset of dementia, stroke, and other neurological disorders. This could lead to new treatments and preventive measures. Researchers will be better able to identify factors that affect the brain, such as how depression, stroke, or Alzheimer’s disease are influenced by our genes, environment, and lifestyle.

The largest-ever brain study dataset will help reveal subtle insights. The expansion of genetic data, along with blood samples and survey data collected from everyday life, will further enrich research resources.

Prevention of Osteonecrosis and Fractures

We hope this study will help prevent bone fractures caused by osteoporosis. This is a significant public health issue, costing the UK over £3 billion annually. It also provides an opportunity to investigate the relationship between bone mass and other common chronic non-communicable diseases associated with osteoporosis, such as diabetes, atherosclerosis, hypertension, dementia, and sarcopenia.

Insights into Cardiovascular Disease

This imaging study will provide unprecedented assistance in researching the heart itself. The findings will also serve as research material for scientists in the UK and abroad. The imaging scans will enable researchers to examine cardiac health in greater detail than was previously possible. In the future, this research will not only facilitate faster and more effective cardiac scanning using magnetic resonance imaging (MRI) technology, but also help prevent and treat heart disease.

Understanding Fat Distribution

Magnetic resonance imaging (MRI) scans will also provide substantial and critical information regarding the distribution of fat and muscle mass. Integrating these data with information on lifestyle, genetics, and blood-based markers (such as hormones, blood glucose, and cholesterol) will significantly enhance the UK Biobank’s research into obesity, diabetes, hypertension, hyperlipidemia, cardiovascular disease, certain cancers, and other complications. Growing evidence indicates that fat distribution, rather than total fat mass, is crucial for assessing an individual’s risk of developing future diseases. Abdominal MRI offers an excellent opportunity to examine specific fat depots—including visceral, hepatic, and pancreatic fat—and disease-related adipose tissue distribution patterns.

How the Study Will Be Conducted

The research project is sponsored by the Medical Research Council and utilizes a dedicated suite of scanning tools at the UK Biobank headquarters in Stockport to initially study 8,000 participants. Individuals undergoing scanning will not receive personal health feedback unless serious abnormalities are detected during the imaging process. The imaging will include:

MRI analysis of cardiac chamber diameters, blood flow volumes, and dynamic cardiac changes during systemic pumping, as well as MRI assessment of the thoracic aorta—the vessel that transports blood from the heart—including its size, shape, and stiffness;

MRI scans for mapping brain structure and function, gray matter volume, and brain connectivity;

Dual-energy X-ray assessment of bone mineral density, osteoarthritic changes in the spine, hip, and knee joints, spinal fractures, and whole-body fat distribution;

Magnetic resonance imaging (MRI) assessment of abdominal fat, including the liver and pancreas;

Ultrasound Assessment of the Two Major Carotid Arteries Running from the Neck to Both Sides of the Brain.

Background Information

Biobank refers to a repository that collects and stores biological samples such as human tissues, plasma, and body fluids. Like “health banks,” it is an abbreviated term for entities with generalized banking characteristics. Biobanks collect, store, and analyze individuals’ biological samples throughout their lifetimes to provide personal health information for disease prevention and prediction, document family genetic histories, and support medical scientific research.

The UK Biobank contains samples and health data from 500,000 individuals. Conducted between 2006 and 2010 with an investment of £62 million, this project—primarily funded by the UK Medical Research Council and the Wellcome Trust—surveyed individuals aged 40 to 69 across the United Kingdom at a sampling ratio of 1:50.

Translation: Liu Jianqiu

Editor: Li Simeng